Rabeprazole Sodium EC Pellets Manufacturer in India

Rabeprazole Sodium EC Pellets – Pharmaceutical-Grade Enteric-Coated Pellets

Rabeprazole Sodium EC Pellets are pharmaceutical-grade enteric-coated multiparticulate pellets containing Rabeprazole Sodium. Rabeprazole Sodium has the anhydrous molecular formula C₁₈H₂₀N₃NaO₃S, molecular weight 381.42 g/mol, and CAS Number 117976-90-6. USP specifies Rabeprazole Sodium at 98.0–102.0%, calculated on the dried basis for the anhydrous material or anhydrous basis for the hydrated form.

Rabeprazole Sodium is sensitive to acidic conditions. Enteric-coated pellet technology is therefore used to provide acid resistance followed by release under suitable gastrointestinal conditions. Published formulation work has demonstrated Rabeprazole Sodium pellets with an enteric coating designed around a pH-dependent dissolution threshold, including coatings based on polymers that dissolve at approximately pH 5.5 and above.

Commercial Rabeprazole Sodium EC pellet products are available in several active loadings. Documented commercial strengths include 7.5%, 8.5%, 15%, 20%, 22.5% and 25% w/w, depending on the manufacturer and formulation.

For SDP, the final published strength should be taken from the current SDP product specification or COA rather than assuming the entire commercial range.

Key Features

• Pharmaceutical-grade Rabeprazole Sodium EC Pellets
• Enteric-coated multiparticulate formulation
• Active ingredient: Rabeprazole Sodium
• Designed for acid-resistant performance
• pH-dependent delayed-release profile
• Suitable for capsule-filling applications
• Suitable for multiparticulate oral dosage forms
• Product-specific active loading
• Controlled coating and dissolution characteristics
• Suitable for bulk pharmaceutical formulation requirements

Applications

Enteric-Coated Oral Formulations

Rabeprazole Sodium EC Pellets are designed for formulations requiring protection from acidic gastric conditions.

Capsule Filling

The multiparticulate pellet format is suitable for incorporation into capsule dosage forms according to the required strength and formulation specification.

Delayed-Release Formulations

The enteric coating provides acid resistance followed by release under the defined pH conditions.

Pharmaceutical Formulation Development

The pellets can be used as a formulation intermediate for development, optimization and manufacturing of oral multiparticulate products.

Bulk Pharmaceutical Supply

Rabeprazole Sodium EC Pellets can be supplied for bulk formulation requirements with product-specific loading, pellet size, coating and dissolution specifications.

Why Rabeprazole Sodium EC Pellets from Swapnroop?

• Pharmaceutical-Grade Pellets – Designed for pharmaceutical formulation applications.
• Enteric-Coated Format – Designed to protect the active ingredient under acidic conditions.
• Delayed-Release Profile – Supports pH-dependent release according to the approved formulation specification.
• Product-Specific Active Loading – Rabeprazole Sodium concentration is controlled according to the applicable product specification.
• Multiparticulate Format – Suitable for capsule filling and other oral multiparticulate applications.
• Controlled Pellet Characteristics – Pellet size, coating weight, acid resistance and dissolution can be controlled according to the product specification.
• Formulation Flexibility – Suitable for enteric-coated formulation development.
• Bulk Pharmaceutical Supply – Suitable for pharmaceutical manufacturers requiring bulk pellet intermediates.
• Rabeprazole Sodium Pellet Supplier Support – Product and supply parameters can be aligned with customer formulation requirements.

Get Bulk Quote via WhatsApp